Edwards Lifesciences to release 10-year study results on surgical valve tissue technology
Updated
Updated · The Wall Street Journal · Apr 25
Edwards Lifesciences to release 10-year study results on surgical valve tissue technology
5 articles · Updated · The Wall Street Journal · Apr 25
The company’s findings, covering its latest generation of surgical valves, will be published in early May 2026.
The study aims to address long-term durability of tissue valves, a key concern for younger patients considering surgical or transcatheter aortic valve replacement options.
With over 13% of Americans aged 75+ affected by aortic stenosis, the results could influence treatment guidelines and future valve technology development for both older and younger patient populations.
Is a forgotten open-heart surgery now the best long-term fix over high-tech TAVR?
As TAVR sales boom, are long-term patient outcomes being sacrificed for profit?
Could new plastic-like valves soon make the entire TAVR durability debate obsolete?
AI can detect silent heart disease years early. Should we operate before symptoms appear?
One study shows TAVR is safe; another shows higher death rates. Who should patients believe?